Oxomemazine
Oxomemazine is an antihistamine and anticholinergic of the phenothiazine chemical class for the treatment of cough.[1][2]
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.020.906 |
Chemical and physical data | |
Formula | C18H22N2O2S |
Molar mass | 330.444 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
See also
References
- Pujet, J. C.; Keddad, K.; Sévenier, F.; Jolivet-Landreau, I. (2002). "Comparative study of two antitussive drugs in the treatment of acute dry cough of infectious origin (prospective, randomized, single blind study)". Thérapie. 57 (5): 457–463. PMID 12611200.
- Lee, S. W.; Woo, C. W.; Kim, J. G. (1994). "Selectivity of oxomemazine for the M1 muscarinic receptors". Archives of Pharmacal Research. 17 (6): 443–451. doi:10.1007/BF02979123. PMID 10319156.
Benzimidazoles (*) | |
---|---|
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
Histamine receptor modulators | |
---|---|
H1 |
|
H2 |
|
H3 |
|
H4 |
|
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors |
Classes |
|
---|---|
Antidepressants (TCAs and TeCAs) |
|
Antihistamines |
|
Antipsychotics |
|
Anticonvulsants | |
Others |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.